Andexanet controlled factor Xa inhibitor–related bleeding

The factor Xa antidote andexanet achieved effective hemostasis 12 hours after infusion in 79% of patients who had developed serious acute bleeding on factor Xa inhibitor therapy, according to a...
Source: Hospitalist News - Category: Hospital Management Source Type: research